OrbiMed Genesis GP LLC - Insider Non-Derivative Transactions at Keros Therapeutics, Inc. (KROS) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 21, 2025, OrbiMed Genesis GP LLC's relationship to Keros Therapeutics, Inc. (KROS) is Director, and currently has 759,155 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other KROS insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

OrbiMed Genesis GP LLC - Insider Non-Derivative Transactions of KROS Common Stock

OrbiMed Genesis GP LLC - Insider Non-Derivative Transactions at KROS

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 22, 2025	Disposition -- (Common Stock)	74465	17.75	45057
Nov 22, 2025	Disposition -- (Common Stock)	140057	17.75	759155
Aug 14, 2024	Sell -- (Common Stock)	29400	44.01	119522
Aug 14, 2024	Sell -- (Common Stock)	220600	44.01	899212